What happened: NFL chief medical officer Allen Sills said superficial blood clots are not a novel condition. He said the league tracks blood-clot data and shares it with the NFLPA. He said each case carries extenuating circumstances for clearance decisions.

Why it matters: Clearance authority rests with team medical staffs under league protocols. Continued confidence in the Philadelphia Eagles medical staff frames trust in that process. Shared league-union data provides a common baseline for evaluating future cases.

What to watch: Watch whether the league discloses any aggregated clot findings. Teams will continue to manage clearance decisions case by case.